Advertisement

Contemporary Diagnosis: Imaging Modalities – Overview

  • Jovan N. Markovic
  • Cynthia K. Shortell
Chapter

Abstract

Congenital vascular malformations (CVMs) represent complex group of vascular lesions caused by embryologic dysmorphogenesis with normal rate of endothelial proliferation that can lead to anomalies of the vascular system characterized by wide range of presenting symptoms and often unpredictable clinical course [1–5]. Clinical evaluation often underestimates the involvement of deep structures such as muscles, bones, joints, or abdominal viscera and is not sufficient to differentiate high-flow from low-flow lesions and malformations from tumors in some of the more complex cases [6–9]. Limitations in diagnosis and treatment resulted from inadequate classification schema and diagnostic algorithms that traditionally characterized management of these vascular lesions [10, 11]. A relatively recent advancement in the diagnostic and treatment modalities have resulted in a better understanding of the pathophysiology and natural history of CVMs and improved management of these lesions.

References

  1. 1.
    Cohen Jr MM. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Genet. 2002;108(4):265–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Diehl S et al. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. Pediatr Res. 2005;57(4):537–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3:1583–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Calvert JT et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet. 1999;8(7):1279–89.CrossRefPubMedGoogle Scholar
  5. 5.
    Irrthum A, Brouillard P, Boon LM, Warman ML, Olsen BR, Mulliken JB, Enjolras O, Vikkula M. Linkage disequilibrium narrows locus for venous malformations with glomus cells (VMGLOM) to a single 1.48-Mbp YAC. Eur J Hum Genet. 2001;9:34–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg. 1993;6:219–24.PubMedGoogle Scholar
  7. 7.
    Lee BB, Laredo J. Classification of congenital vascular malformations: the last challenge for congenital vascular malformations. Phlebology. 2012;27(6):267–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology. 2007;22(6):249–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Marler JJ, Mulliken JB. Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am. 2001;9(4):495–504.PubMedGoogle Scholar
  10. 10.
    Lee BB, Laredo J, Seo JM, Neville R. Chapter 29. Treatment of lymphatic malformations. In: Mattassi, Loose, Vaghi, editors. Hemangiomas and vascular malformations. Milan, Italy: Springer-Verlag Italia; 2009. p. 231–50.Google Scholar
  11. 11.
    Lee BB. Advanced management of congenital vascular malformation (CVM). Int Angiol. 2002;21(3):209–13.PubMedGoogle Scholar
  12. 12.
    Lee BB, Mattassi R, Choe YH, Vaghi M, Ahn JM, Kim DI, Huh SH, Lee CH, Kim DY. Critical role of duplex ultrasonography for the advanced management of a venous malformation (VM). Phlebology. 2005;20:28–37.CrossRefGoogle Scholar
  13. 13.
    Gold L, Nazarian LN, Johar AS, Rao VM. Characterization of maxillofacial soft tissue vascular anomalies by ultrasound and color Doppler imaging: an adjuvant to computed tomography and magnetic resonance imaging. J Oral Maxillofac Surg. 2003;61(1):19–31.CrossRefPubMedGoogle Scholar
  14. 14.
    Rauch RF, Silverman PM, Korobkin M, et al. Computed tomography of benign angiomatous lesions of the extremities. J Comput Assist Tomogr. 1984;8:1143–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol. 1983;141(3):483–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee BB, Mattassi R, Kim BT, Park JM. Advanced management of arteriovenous shunting malformation with transarterial Lung Perfusion Scintigraphy (TLPS) for follow up assessment. Int Angiol. 2005;24(2):173–84.PubMedGoogle Scholar
  17. 17.
    Lee BB, Mattassi R, Kim BT, Kim DI, Ahn JM, Choi JY. Contemporary diagnosis and management of venous and AV shunting malformation by whole body blood pool scintigraphy (WBBPS). Int Angiol. 2004;23:355–67.PubMedGoogle Scholar
  18. 18.
    Lee BB, Bergan J, Gloviczki P, Laredo J, Loose DA, Mattassi R, Parsi K, Villavicencio JL, Zamboni P. Diagnosis and treatment of venous malformations – Consensus Document of the International Union of Phlebology (IUP)-2009. Int Angiol. 2009;28(6):434–51.PubMedGoogle Scholar
  19. 19.
    Moukaddam H, Pollak J, Haims AH. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol. 2009;38(6):535–47.CrossRefPubMedGoogle Scholar
  20. 20.
    Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am. 2002;10(2):363–88.CrossRefPubMedGoogle Scholar
  21. 21.
    Van Rijswijk CS, van der Linden E, van der Woude HJ, van Baalen JM, Bloem JL. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol. 2002;178(5):1181–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Lidsky M, Spritzer C, Shortell C. The role of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis and management of patients with vascular malformations. J Vasc Surg. 2011;53(1):131–7.CrossRefGoogle Scholar
  23. 23.
    Markovic JN, Shortell CK. Multidisciplinary treatment of the extremity vascular malformations. J Vasc Surg-Venous Lymphat Disord. 2015;3:209–18.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations